Harvard Bioscience to Showcase Latest Innovations in Preclinical and Organoid Research at Society for Neuroscience Conference on November 12-15, 2023

Grand News Network | November 6, 2023

HOLLISTON, Mass., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) today announced that it will be showcasing its latest product innovations at the Society for Neuroscience (SfN) conference from November 12-15, 2023, in Washington, D.C. Complementing an already extensive product line, the new innovations provide exciting new opportunities for advancing preclinical and organoid-focused research and therapy development by a broad range of customers.

The latest advancements from the Company's Data Sciences International (DSI) preclinical business expand the reach of DSI's industry-leading, GLP-compliant Ponemah™ preclinical data management platform. These advancements include DSI's new SoHo™ implantable telemetry solution for small animal models and its VivaMARS™ high-capacity behavior monitoring system.

Integrated with the Ponemah platform, the SoHo implantable real-time telemetry solution enables researchers to collect, manage, analyze and report findings from multiple concurrent small animal models in a more natural shared housing environment. In addition, the SoHo solution allows data to be collected over longer time periods and opens exciting new opportunities for longitudinal studies. The SoHo solution is designed to support the customer's business needs by reducing operating costs and test cycle times, enabling increased testing throughput.

The VivaMARS system combines the Company's real-time high precision Panlab® activity monitoring technology with its Ponemah preclinical data management platform to create an integrated GLP-compliant solution. The system is ideally suited to meet the high throughput, automated neuropharmacology and neurotoxicology testing needs of CROs and pharma companies, in addition to longitudinal behavior studies carried out by leading research and academic institutes. For more information on the VivaMARS system, please visit the DSI website at

Full story available on Benzinga.com


Disclaimer: The views, recommendations, and opinions expressed in this content belong solely to the third-party experts. This site was not involved in the writing and production of this article.


Disclaimer Press Release Banner

Copyright © 2024 | All rights reserved